Profile of vortioxetine in the treatment of major depressive disorder: An overview of the primary and secondary literature

Marc Kelliny, Paul E. Croarkin, Katherine M. Moore, William V. Bobo

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


This article reviews the pharmacological profile and available efficacy and tolerability/safety data for vortioxetine, one of the most recent antidepressant drugs to be approved in the USA for the treatment of major depressive disorder (MDD) in adults. The efficacy of vortioxetine for treating MDD in adults is supported by eight positive short-term (6- to 12-weeks) randomized, placebo-controlled trials, and one positive randomized, double-blind, 52-week relapse prevention trial. Based on pooled data from short-term randomized trials and from longer-term studies, vortioxetine appears to be well tolerated and to have a low incidence of adverse effects on sexual functioning. Vortioxetine also appears to be effective for treating symptoms of MDD in the elderly based on the results of one randomized trial for which recruitment was focused on this specific population. Nevertheless, effectiveness studies that directly compare the clinical effects of vortioxetine with other established antidepressant drugs are lacking, and there is no evidence as yet that vortioxetine is more clinically effective than other types of antidepressants. Some preliminary suggestions concerning the place of vortioxetine among the broad range of pharmacological treatments for adults with MDD are provided.

Original languageEnglish (US)
Pages (from-to)1193-1212
Number of pages20
JournalTherapeutics and Clinical Risk Management
StatePublished - Aug 12 2015


  • Adverse effects/side effects/safety
  • Depression
  • Drug interactions
  • Lu AA21004
  • Major depression
  • Pharmacokinetics
  • Pharmacological profile
  • Vortioxetine

ASJC Scopus subject areas

  • Safety Research
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)
  • Chemical Health and Safety


Dive into the research topics of 'Profile of vortioxetine in the treatment of major depressive disorder: An overview of the primary and secondary literature'. Together they form a unique fingerprint.

Cite this